Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program.

Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program.

<h4>Objective</h4>The objective was to determine the safety of ocrelizumab (OCR) in patients with rheumatoid arthritis (RA).<h4>Methods</h4>This was an analysis of the double-blind, placebo-controlled periods and long-term follow-up of 4 OCR phase III trials in RA (SCRIPT, ST...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paul Emery, William Rigby, Paul P Tak, Thomas Dörner, Ewa Olech, Carmen Martin, Laurie Millar, Helen Travers, Elena Fisheleva
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/49652c7e07ca420993dde7e84ab236dd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares